Recent cardiovascular outcome trials have demonstrated significant reductions in major adverse cardiovascular events in patients using these medications, making them valuable not just for weight loss but for overall cardiovascular health
A Facebook community is available, but there is no structured guidance
Resistance to viral diseases therefore correlates positively with the extent of glutathione stores
People with a personal or family history of thyroid cancer should not take semaglutide, and this may apply to retatrutide as well, pending FDA review
Patients were excluded if they had any other chronic liver disease other than MASLD/MASH including alcohol, viral, drug-induced, autoimmune, Budd-Chiari syndrome, Wilsons disease, alpha-1-antitrypsin deficiency, hereditary hemochromatosis, primary/secondary biliary cholangitis, primary sclerosing cholangitis, liver disorders in diseases classified elsewhere, and other chronic hepatitis not classified elsewhere
Schedule a consultation today to get a professional tune-up for your weight loss plan